These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 35478)
21. Treatment of female schizophrenic patients with bromperidol, a new neuroleptic drug of the butyrophenone group with medium duration of action. Fleischhauer J Acta Psychiatr Belg; 1978; 78(1):118-28. PubMed ID: 347874 [TBL] [Abstract][Full Text] [Related]
22. An early phase II clinical trial of remoxipride in schizophrenia with measurement of plasma neuroleptic activity. Chouinard G; Turnier L Psychopharmacol Bull; 1986; 22(1):267-71. PubMed ID: 2873615 [No Abstract] [Full Text] [Related]
23. [Difficulties of evaluation of the results of drug treatment of schizophrenia]. Welbel L Psychiatr Pol; 1980; 14(1):51-7. PubMed ID: 6102774 [No Abstract] [Full Text] [Related]
24. [Is depot formulation a long-term optimal treatment option?]. Musch A Med Monatsschr Pharm; 2005 Nov; 28(11):414-6. PubMed ID: 16309031 [No Abstract] [Full Text] [Related]
25. Aripiprazole: new drug. Just another neuroleptic. Prescrire Int; 2005 Oct; 14(79):163-7. PubMed ID: 16285069 [TBL] [Abstract][Full Text] [Related]
26. Negative symptoms in nondeficit syndrome respond to neuroleptic treatment with changes in plasma homovanillic acid concentrations. Suzuki E; Kanba S; Koshikawa H; Nibuya M; Yagi G; Asai M J Psychiatry Neurosci; 1996 May; 21(3):167-71. PubMed ID: 8935328 [TBL] [Abstract][Full Text] [Related]
27. Risperidone for chronic schizophrenia. Med Lett Drugs Ther; 1994 Apr; 36(920):33-4. PubMed ID: 7511777 [No Abstract] [Full Text] [Related]
28. [Neuroleptic malignant syndrome. Case reports]. Berardi D; Troia M; Veronesi L; Ferrari G Minerva Psichiatr; 1994 Dec; 35(4):199-219. PubMed ID: 7861943 [TBL] [Abstract][Full Text] [Related]
29. Quetiapine for schizophrenia. Med Lett Drugs Ther; 1997 Dec; 39(1016):117-8. PubMed ID: 9422044 [No Abstract] [Full Text] [Related]
30. The efficacy of piquindone, a new atypical neuroleptic, in the treatment of the positive and negative symptoms of schizophrenia. Cohen JD; Van Putten T; Marder S; Berger PA; Stahl SM J Clin Psychopharmacol; 1987 Oct; 7(5):324-9. PubMed ID: 2890671 [TBL] [Abstract][Full Text] [Related]
31. [Improvement of tardive dyskinesia with high doses of propranolol]. Moreira MJ; Karniol IG Rev Paul Med; 1979; 93(3-4):76-8. PubMed ID: 40299 [No Abstract] [Full Text] [Related]
32. Schizophrenia: recent advances in psychopharmacology. Sharma T Br J Hosp Med; 1996 Feb 21-Mar 5; 55(4):194-8. PubMed ID: 8777500 [No Abstract] [Full Text] [Related]
33. Tardive dyskinesia in schizophrenic outpatients: prevalence and significant variables. Ezrin-Waters C; Seeman MV; Seeman P J Clin Psychiatry; 1981 Jan; 42(1):16-22. PubMed ID: 6109715 [TBL] [Abstract][Full Text] [Related]
34. Dose selection and comparator drugs in schizophrenia research. Kane JM J Clin Psychiatry; 2001; 62 Suppl 9():29-32; discussion 33-4. PubMed ID: 11379828 [TBL] [Abstract][Full Text] [Related]
35. Myth and reality of pragmatic trials. Mohr P; Bitter I; Constant E; Jakovljević M; Jarema M; Pecenak J; Seifritz E; Svestka J; Sartorius N Psychiatr Danub; 2010 Mar; 22(1):2-3. PubMed ID: 20305584 [No Abstract] [Full Text] [Related]
36. [Benzamides, a therapeutic response adapted to 2 sides, paranoid and hebephrenic, of schizophrenia]. Cassan P Ann Med Psychol (Paris); 1985 Jul; 143(7):677-82. PubMed ID: 2870674 [No Abstract] [Full Text] [Related]
37. [Treatment of schizophrenia]. Houy-Durand E; Thibaut F Rev Prat; 2002 Jun; 52(11):1213-20. PubMed ID: 12148207 [TBL] [Abstract][Full Text] [Related]
39. [Continuity in the neuroleptic treatment in patients with schizophrenia. Current data]. Tignol J; Plagnol C; Auriacombe M; Cazenave M; O'Brien CP Ann Med Psychol (Paris); 1990 Mar; 148(3):290-3. PubMed ID: 1978624 [No Abstract] [Full Text] [Related]